0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Coagulation Factor VIII Market Research Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-28D484
Home | Market Reports | Health| Pharmacy
Global Human Coagulation Factor VIII Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Coagulation Factor VIII Market Research Report 2023

Code: QYRE-Auto-28D484
Report
January 2023
Pages:91
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Human Coagulation Factor VIII Market

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
The global Human Coagulation Factor VIII market was valued at US$ 10230 million in 2022 and is anticipated to reach US$ 15770 million by 2029, witnessing a CAGR of 6.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.
The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS

Segment by Type

  • Recombinant Factor VIII
  • Plasma-derived Factor VIII

Segment by Application

  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Other

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Coagulation Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Human Coagulation Factor VIII Market Report

Report MetricDetails
Report NameGlobal Human Coagulation Factor VIII Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Human Coagulation Factor VIII Market Overview
1.1 Product Overview and Scope of Human Coagulation Factor VIII
1.2 Human Coagulation Factor VIII Segment by Type
1.2.1 Global Human Coagulation Factor VIII Market Value Comparison by Type (2023-2029)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII Segment by Application
1.3.1 Global Human Coagulation Factor VIII Market Value by Application: (2023-2029)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts
1.4.1 Global Human Coagulation Factor VIII Revenue 2018-2029
1.4.2 Global Human Coagulation Factor VIII Sales 2018-2029
1.4.3 Global Human Coagulation Factor VIII Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Coagulation Factor VIII Market Competition by Manufacturers
2.1 Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Coagulation Factor VIII Average Price by Manufacturers (2018-2023)
2.4 Global Human Coagulation Factor VIII Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Coagulation Factor VIII, Product Type & Application
2.7 Human Coagulation Factor VIII Market Competitive Situation and Trends
2.7.1 Human Coagulation Factor VIII Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Coagulation Factor VIII Players Market Share by Revenue
2.7.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Coagulation Factor VIII Retrospective Market Scenario by Region
3.1 Global Human Coagulation Factor VIII Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Coagulation Factor VIII Global Human Coagulation Factor VIII Sales by Region: 2018-2029
3.2.1 Global Human Coagulation Factor VIII Sales by Region: 2018-2023
3.2.2 Global Human Coagulation Factor VIII Sales by Region: 2024-2029
3.3 Global Human Coagulation Factor VIII Global Human Coagulation Factor VIII Revenue by Region: 2018-2029
3.3.1 Global Human Coagulation Factor VIII Revenue by Region: 2018-2023
3.3.2 Global Human Coagulation Factor VIII Revenue by Region: 2024-2029
3.4 North America Human Coagulation Factor VIII Market Facts & Figures by Country
3.4.1 North America Human Coagulation Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Coagulation Factor VIII Sales by Country (2018-2029)
3.4.3 North America Human Coagulation Factor VIII Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Coagulation Factor VIII Market Facts & Figures by Country
3.5.1 Europe Human Coagulation Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Coagulation Factor VIII Sales by Country (2018-2029)
3.5.3 Europe Human Coagulation Factor VIII Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Coagulation Factor VIII Market Facts & Figures by Country
3.6.1 Asia Pacific Human Coagulation Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Coagulation Factor VIII Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Coagulation Factor VIII Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Coagulation Factor VIII Market Facts & Figures by Country
3.7.1 Latin America Human Coagulation Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Coagulation Factor VIII Sales by Country (2018-2029)
3.7.3 Latin America Human Coagulation Factor VIII Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Coagulation Factor VIII Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Coagulation Factor VIII Sales by Type (2018-2029)
4.1.1 Global Human Coagulation Factor VIII Sales by Type (2018-2023)
4.1.2 Global Human Coagulation Factor VIII Sales by Type (2024-2029)
4.1.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2018-2029)
4.2 Global Human Coagulation Factor VIII Revenue by Type (2018-2029)
4.2.1 Global Human Coagulation Factor VIII Revenue by Type (2018-2023)
4.2.2 Global Human Coagulation Factor VIII Revenue by Type (2024-2029)
4.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2018-2029)
4.3 Global Human Coagulation Factor VIII Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Coagulation Factor VIII Sales by Application (2018-2029)
5.1.1 Global Human Coagulation Factor VIII Sales by Application (2018-2023)
5.1.2 Global Human Coagulation Factor VIII Sales by Application (2024-2029)
5.1.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2018-2029)
5.2 Global Human Coagulation Factor VIII Revenue by Application (2018-2029)
5.2.1 Global Human Coagulation Factor VIII Revenue by Application (2018-2023)
5.2.2 Global Human Coagulation Factor VIII Revenue by Application (2024-2029)
5.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2018-2029)
5.3 Global Human Coagulation Factor VIII Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Shire (Baxter)
6.1.1 Shire (Baxter) Corporation Information
6.1.2 Shire (Baxter) Description and Business Overview
6.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
6.1.5 Shire (Baxter) Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CSL Human Coagulation Factor VIII Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Grifols
6.5.1 Grifols Corporation Information
6.5.2 Grifols Description and Business Overview
6.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
6.5.5 Grifols Recent Developments/Updates
6.6 Biogen
6.6.1 Biogen Corporation Information
6.6.2 Biogen Description and Business Overview
6.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
6.6.5 Biogen Recent Developments/Updates
6.7 Octapharma
6.6.1 Octapharma Corporation Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Octapharma Human Coagulation Factor VIII Product Portfolio
6.7.5 Octapharma Recent Developments/Updates
6.8 NovoNordisk
6.8.1 NovoNordisk Corporation Information
6.8.2 NovoNordisk Description and Business Overview
6.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
6.8.5 NovoNordisk Recent Developments/Updates
6.9 Greencross
6.9.1 Greencross Corporation Information
6.9.2 Greencross Description and Business Overview
6.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
6.9.5 Greencross Recent Developments/Updates
6.10 Kedrion
6.10.1 Kedrion Corporation Information
6.10.2 Kedrion Description and Business Overview
6.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
6.10.5 Kedrion Recent Developments/Updates
6.11 BPL
6.11.1 BPL Corporation Information
6.11.2 BPL Human Coagulation Factor VIII Description and Business Overview
6.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BPL Human Coagulation Factor VIII Product Portfolio
6.11.5 BPL Recent Developments/Updates
6.12 Hualan Bio
6.12.1 Hualan Bio Corporation Information
6.12.2 Hualan Bio Human Coagulation Factor VIII Description and Business Overview
6.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
6.12.5 Hualan Bio Recent Developments/Updates
6.13 RAAS
6.13.1 RAAS Corporation Information
6.13.2 RAAS Human Coagulation Factor VIII Description and Business Overview
6.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2018-2023)
6.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
6.13.5 RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Coagulation Factor VIII Industry Chain Analysis
7.2 Human Coagulation Factor VIII Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Coagulation Factor VIII Production Mode & Process
7.4 Human Coagulation Factor VIII Sales and Marketing
7.4.1 Human Coagulation Factor VIII Sales Channels
7.4.2 Human Coagulation Factor VIII Distributors
7.5 Human Coagulation Factor VIII Customers
8 Human Coagulation Factor VIII Market Dynamics
8.1 Human Coagulation Factor VIII Industry Trends
8.2 Human Coagulation Factor VIII Market Drivers
8.3 Human Coagulation Factor VIII Market Challenges
8.4 Human Coagulation Factor VIII Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Human Coagulation Factor VIII Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Human Coagulation Factor VIII Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Human Coagulation Factor VIII Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Human Coagulation Factor VIII Sales (K Bottles) of Key Manufacturers (2018-2023)
    Table 5. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Human Coagulation Factor VIII Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Human Coagulation Factor VIII Average Price (USD/Bottle) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Human Coagulation Factor VIII, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Human Coagulation Factor VIII, Product Type & Application
    Table 12. Global Key Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Human Coagulation Factor VIII Sales by Region (2018-2023) & (K Bottles)
    Table 18. Global Human Coagulation Factor VIII Sales Market Share by Region (2018-2023)
    Table 19. Global Human Coagulation Factor VIII Sales by Region (2024-2029) & (K Bottles)
    Table 20. Global Human Coagulation Factor VIII Sales Market Share by Region (2024-2029)
    Table 21. Global Human Coagulation Factor VIII Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Human Coagulation Factor VIII Revenue Market Share by Region (2018-2023)
    Table 23. Global Human Coagulation Factor VIII Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Human Coagulation Factor VIII Revenue Market Share by Region (2024-2029)
    Table 25. North America Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
    Table 27. North America Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
    Table 28. North America Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
    Table 32. Europe Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
    Table 33. Europe Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Human Coagulation Factor VIII Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Human Coagulation Factor VIII Sales by Region (2018-2023) & (K Bottles)
    Table 37. Asia Pacific Human Coagulation Factor VIII Sales by Region (2024-2029) & (K Bottles)
    Table 38. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
    Table 42. Latin America Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
    Table 43. Latin America Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
    Table 47. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
    Table 48. Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Human Coagulation Factor VIII Sales (K Bottles) by Type (2018-2023)
    Table 51. Global Human Coagulation Factor VIII Sales (K Bottles) by Type (2024-2029)
    Table 52. Global Human Coagulation Factor VIII Sales Market Share by Type (2018-2023)
    Table 53. Global Human Coagulation Factor VIII Sales Market Share by Type (2024-2029)
    Table 54. Global Human Coagulation Factor VIII Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Human Coagulation Factor VIII Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Human Coagulation Factor VIII Revenue Market Share by Type (2018-2023)
    Table 57. Global Human Coagulation Factor VIII Revenue Market Share by Type (2024-2029)
    Table 58. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2018-2023)
    Table 59. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2024-2029)
    Table 60. Global Human Coagulation Factor VIII Sales (K Bottles) by Application (2018-2023)
    Table 61. Global Human Coagulation Factor VIII Sales (K Bottles) by Application (2024-2029)
    Table 62. Global Human Coagulation Factor VIII Sales Market Share by Application (2018-2023)
    Table 63. Global Human Coagulation Factor VIII Sales Market Share by Application (2024-2029)
    Table 64. Global Human Coagulation Factor VIII Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Human Coagulation Factor VIII Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Human Coagulation Factor VIII Revenue Market Share by Application (2018-2023)
    Table 67. Global Human Coagulation Factor VIII Revenue Market Share by Application (2024-2029)
    Table 68. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2018-2023)
    Table 69. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2024-2029)
    Table 70. Shire (Baxter) Corporation Information
    Table 71. Shire (Baxter) Description and Business Overview
    Table 72. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 73. Shire (Baxter) Human Coagulation Factor VIII Product
    Table 74. Shire (Baxter) Recent Developments/Updates
    Table 75. Bayer Corporation Information
    Table 76. Bayer Description and Business Overview
    Table 77. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 78. Bayer Human Coagulation Factor VIII Product
    Table 79. Bayer Recent Developments/Updates
    Table 80. CSL Corporation Information
    Table 81. CSL Description and Business Overview
    Table 82. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 83. CSL Human Coagulation Factor VIII Product
    Table 84. CSL Recent Developments/Updates
    Table 85. Pfizer Corporation Information
    Table 86. Pfizer Description and Business Overview
    Table 87. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 88. Pfizer Human Coagulation Factor VIII Product
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Grifols Corporation Information
    Table 91. Grifols Description and Business Overview
    Table 92. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 93. Grifols Human Coagulation Factor VIII Product
    Table 94. Grifols Recent Developments/Updates
    Table 95. Biogen Corporation Information
    Table 96. Biogen Description and Business Overview
    Table 97. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 98. Biogen Human Coagulation Factor VIII Product
    Table 99. Biogen Recent Developments/Updates
    Table 100. Octapharma Corporation Information
    Table 101. Octapharma Description and Business Overview
    Table 102. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 103. Octapharma Human Coagulation Factor VIII Product
    Table 104. Octapharma Recent Developments/Updates
    Table 105. NovoNordisk Corporation Information
    Table 106. NovoNordisk Description and Business Overview
    Table 107. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 108. NovoNordisk Human Coagulation Factor VIII Product
    Table 109. NovoNordisk Recent Developments/Updates
    Table 110. Greencross Corporation Information
    Table 111. Greencross Description and Business Overview
    Table 112. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 113. Greencross Human Coagulation Factor VIII Product
    Table 114. Greencross Recent Developments/Updates
    Table 115. Kedrion Corporation Information
    Table 116. Kedrion Description and Business Overview
    Table 117. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 118. Kedrion Human Coagulation Factor VIII Product
    Table 119. Kedrion Recent Developments/Updates
    Table 120. BPL Corporation Information
    Table 121. BPL Description and Business Overview
    Table 122. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 123. BPL Human Coagulation Factor VIII Product
    Table 124. BPL Recent Developments/Updates
    Table 125. Hualan Bio Corporation Information
    Table 126. Hualan Bio Description and Business Overview
    Table 127. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 128. Hualan Bio Human Coagulation Factor VIII Product
    Table 129. Hualan Bio Recent Developments/Updates
    Table 130. RAAS Corporation Information
    Table 131. RAAS Description and Business Overview
    Table 132. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 133. RAAS Human Coagulation Factor VIII Product
    Table 134. RAAS Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Human Coagulation Factor VIII Distributors List
    Table 138. Human Coagulation Factor VIII Customers List
    Table 139. Human Coagulation Factor VIII Market Trends
    Table 140. Human Coagulation Factor VIII Market Drivers
    Table 141. Human Coagulation Factor VIII Market Challenges
    Table 142. Human Coagulation Factor VIII Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Human Coagulation Factor VIII
    Figure 2. Global Human Coagulation Factor VIII Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Human Coagulation Factor VIII Market Share by Type in 2022 & 2029
    Figure 4. Recombinant Factor VIII Product Picture
    Figure 5. Plasma-derived Factor VIII Product Picture
    Figure 6. Global Human Coagulation Factor VIII Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Human Coagulation Factor VIII Market Share by Application in 2022 & 2029
    Figure 8. Hemophilia A
    Figure 9. Spontanous / Trauma
    Figure 10. Surgical
    Figure 11. Other
    Figure 12. Global Human Coagulation Factor VIII Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Human Coagulation Factor VIII Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Human Coagulation Factor VIII Sales (2018-2029) & (K Bottles)
    Figure 15. Global Human Coagulation Factor VIII Average Price (USD/Bottle) & (2018-2029)
    Figure 16. Human Coagulation Factor VIII Report Years Considered
    Figure 17. Human Coagulation Factor VIII Sales Share by Manufacturers in 2022
    Figure 18. Global Human Coagulation Factor VIII Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Human Coagulation Factor VIII Players: Market Share by Revenue in 2022
    Figure 20. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
    Figure 23. North America Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
    Figure 24. U.S. Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
    Figure 27. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Region (2018-2029)
    Figure 35. China Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Taiwan Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Philippines Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
    Figure 46. Latin America Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
    Figure 47. Mexico Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Brazil Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Argentina Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
    Figure 51. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
    Figure 52. Turkey Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. U.A.E Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Global Sales Market Share of Human Coagulation Factor VIII by Type (2018-2029)
    Figure 56. Global Revenue Market Share of Human Coagulation Factor VIII by Type (2018-2029)
    Figure 57. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2018-2029)
    Figure 58. Global Sales Market Share of Human Coagulation Factor VIII by Application (2018-2029)
    Figure 59. Global Revenue Market Share of Human Coagulation Factor VIII by Application (2018-2029)
    Figure 60. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2018-2029)
    Figure 61. Human Coagulation Factor VIII Value Chain
    Figure 62. Human Coagulation Factor VIII Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS